Status:

AVAILABLE

The Randomized Study of Dasatinib and High-Dose Imatinib (600mg) in Suboptimal Responder

Lead Sponsor:

Pusan National University Hospital

Conditions:

Chronic Myeloid Leukemia

Eligibility:

All Genders

18+ years

Brief Summary

Research Hypothesis: Treatment with dasatinib 100 mg QD is superior to imatinib 600 mg QD in terms of complete cytogenetic response (CCyR) in chronic phase (CP) Philadelphia chromosome-positive (Ph+)...

Detailed Description

Study Design: Prospective open-label, randomized two arms, multicenter study for the patients with suboptimal response to standard Tx to evaluate efficacy \& safety of dasatinib (100mg qd) \& imatinib...

Eligibility Criteria

Inclusion

  • Signed written informed consent, at least 18 years old
  • Adequate hepatic renal function
  • Dasatinib naïve patients
  • Patients with cytogenetically and/or molecularly confirmed Philadelphia chromosome or BCR-ABL positive CP-CML who have been treated with standard dose of imatinib.
  • ECOG status: 0-2
  • And one of following criteria for imatinib suboptimal response 1)CP-CML patients who have failed to achieve a CHR at 3 months or MCyR at 6 months of therapy with imatinib 400mg daily. 2)CP-CML patients who have failed to achieve a CCyR at 12 months with imatinib 400mg daily 3)CP-CML patients who have failed to achieve a MMoR (less than 3 log reduction) at 18 months with imatinib 400mg daily 4)CP-CML patients who have lost molecular response by an increase of BCR-ABL more than 10 times regardless treatment duration.

Exclusion

  • Concurrent malignancy
  • Patients who have received SCT
  • Allergy or hypersensitivity reaction to the study drugs
  • Female who are pregnant or breast feeding.
  • T315I mutation
  • History of significant bleeding disorder
  • Women of child bearing potential
  • Uncontrolled or significant CVS disease: IHD. CHF
  • Prior imatinib\>400mg, imatinib\>18 months
  • Intolerance to imatinib 400mg

Key Trial Info

Start Date :

Trial Type :

EXPANDED_ACCESS

End Date :

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT00854841

Last Update

March 3 2009

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.